RxSight Statistics
Share Statistics
RxSight has 40.92M
shares outstanding. The number of shares has increased by 1.52%
in one year.
| 40.92M |
| 1.52% |
| 0.69% |
| 81.74% |
| 32.42M |
| 71 |
| 0.01% |
Short Selling Information
The latest short interest is 4.78M, so 11.68% of the outstanding
shares have been sold short.
| 4.78M |
| 11.68% |
| 12.27% |
| 4.84 |
Valuation Ratios
The PE ratio is -48.67 and the forward
PE ratio is -7.32.
RxSight's PEG ratio is
0.98.
| -48.67 |
| -7.32 |
| 9.55 |
| 2.7 |
| 4.75 |
| -59.69 |
| 0.98 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for RxSight.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 11.36,
with a Debt / Equity ratio of 0.04.
| 11.36 |
| 10.5 |
| 0.04 |
| -0.52 |
| -0.55 |
| -1755.14 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $280.98K |
| $-55.13K |
| 498 |
| 0.44 |
| 1.86 |
Taxes
| 50K |
| -0.18% |
Stock Price Statistics
The stock price has increased by -82% in the
last 52 weeks. The beta is 1.16, so RxSight's
price volatility has been higher than the market average.
| 1.16 |
| -82% |
| 8.63 |
| 18.48 |
| 46.4 |
| 1,410,868 |
Income Statement
In the last 12 months, RxSight had revenue of 139.93M
and earned -27.45M
in profits. Earnings per share was -0.71.
| 139.93M |
| 98.94M |
| -36.86M |
| -27.45M |
| -23.76M |
| -27.38M |
| -0.71 |
Full Income Statement Balance Sheet
The company has 16.71M in cash and 12.3M in
debt, giving a net cash position of 4.41M.
| 16.71M |
| 12.3M |
| 4.41M |
| -622.1M |
| 309.01M |
| 263.49M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -16.95M
and capital expenditures -5.44M, giving a free cash flow of -22.39M.
| -16.95M |
| -5.44M |
| -22.39M |
| -0.58 |
Full Cash Flow Statement Margins
Gross margin is 70.71%, with operating and profit margins of -26.34% and -19.62%.
| 70.71% |
| -26.34% |
| -19.59% |
| -19.62% |
| -16.98% |
| -26.34% |
| -16% |